Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital

Nuevas guías para el uso de la polifarmacia antipsicótica

(2013) Stephen M. Stahl   Revista de Psiquiatria y Salud Mental

Augmentation of clozapine with another pharmacological agent: treatment for refractory schizophrenia in the ‘real world’

(2012) N. B. Pai et al.   ACTA PSYCHIATRICA SCANDINAVICA

Antipsychotic polypharmacy: never say never, but never say always

(2012) Stephen M. Stahl   ACTA PSYCHIATRICA SCANDINAVICA

Clozapine for the treatment of schizophrenia

(2012) Eric Fakra et al.   EXPERT OPINION ON PHARMACOTHERAPY

Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010

(2012) Sally V. J. Bowskill et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

A systematic review of the evidence of clozapine's anti-aggressive effects

(2012) Catherine Frogley et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism

(2012) Georges Vauquelin et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Clozapine resistance: Augmentation strategies

(2011) Stefano Porcelli et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Executive Function Predicts Response to Antiaggression Treatment in Schizophrenia

(2011) Menahem I. Krakowski et al.   JOURNAL OF CLINICAL PSYCHIATRY

Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review

(2011) Iris E. Sommer et al.   SCHIZOPHRENIA BULLETIN

Polypharmacy in schizophrenia

(2010) Mathias Zink et al.   CURRENT OPINION IN PSYCHIATRY

Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study

(2010) MRA Muscatello et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Long-Term Efficacy and Tolerability of Clozapine Combined with Ziprasidone or Risperidone

(2010) A. Kuwilsky et al.   PHARMACOPSYCHIATRY

Augmentation of clozapine with a second antipsychotic - a meta-analysis of randomized, placebo-controlled studies

(2009) D. M. Taylor et al.   ACTA PSYCHIATRICA SCANDINAVICA

Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial

(2009) Michael Berk et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia

(2009) Jae Seung Chang et al.   JOURNAL OF CLINICAL PSYCHIATRY

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

(2009) Atheir I. Abbas et al.   PSYCHOPHARMACOLOGY

Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial

(2008) M Zink et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Amisulpride Augmentation in Patients with Schizophrenia Partially Responsive or Unresponsive to Clozapine. A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) H.-J. Assion et al.   PHARMACOPSYCHIATRY

Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

(2008) C. U. Correll et al.   SCHIZOPHRENIA BULLETIN